Sernova Seeks Cash And A Partner To Move Type 1 Diabetes Cell Therapy Forward

12 Mar 2024

• By Jessica Merrill

The company’s CEO Cynthia Pussinen joined the company last year and talked to Scrip about her plans to advance a cell therapy for type 1 diabetes.

insulin injection — Sernova is working on a drug/device that would eliminate insulin injections for type 1 diabetes • Source: Shutterstock

More from Alimentary/Metabolic

More from Therapy Areas